Anterix (ATEX) EBITDA (2013 - 2026)

Anterix (ATEX) has reported EBITDA for 14 consecutive years, with -$246000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBITDA fell 101.09% year-over-year to -$246000.0; the trailing twelve-month figure through Jun 2026 stood at $71.2 million (up 176.21% YoY), and the FY2026 full-year result was $94.4 million, up 942.07% from the prior year.
• EBITDA declined to -$246000.0 in Q2 2026 per ATEX's latest filing, from $19.8 million in the prior quarter.
• Across five years, EBITDA topped out at $60.7 million in Q3 2025 and bottomed at -$15.0 million in Q2 2024.
• Historically, EBITDA has averaged $2.5 million across 5 years, with a median of -$1.5 million in 2023.
• The widest YoY moves for EBITDA: up 625.7% in 2024, down 681.23% in 2024.
• Over 5 years, EBITDA stood at -$8.4 million in 2022, then soared by 111.53% to $969000.0 in 2023, then jumped by 625.7% to $7.0 million in 2024, then tumbled by 228.85% to -$9.1 million in 2025, then surged by 97.29% to -$246000.0 in 2026.
• According to Business Quant data, EBITDA over the past three periods registered -$246000.0, $19.8 million, and -$9.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.